HealthcareGlobal

₹355.5 -5.4 | 1.5%

WEBSITE BSE:539787 NSE : HCG 10 May, 16:01

Market Cap ₹4951 Cr.

Stock P/E 140.4

P/B 5.7

Current Price ₹355.5

Book Value ₹ 61.8

Face Value 10

52W High ₹401

Dividend Yield 0%

52W Low ₹ 273

Edit Ratio

HealthcareGlobal Research see more...

Overview Inc. Year: 1998Industry: Hospital & Healthcare Services

HealthCare Global Enterprises Ltd is engaged in dealing with cancer hospitals, cancer centres and medical diagnostic offerings, consisting of scientific testing and consultancy services in the pharmaceutical and clinical zone. The Company is in retail sale of prescribed drugs, clinical and orthopaedic goods and toilet articles. It operates cancer care community below the HCG logo. It operates infertility remedy clinics presenting assisted reproductive offerings beneath emblem Milann. The Company operates eight Milann fertility facilities, which give reproductive medicine services, along with assisted reproduction, gynaecological endoscopy and fertility preservation; and comply with a multidisciplinary and technology-focused method to diagnosis and treatment. Milann fertility centers additionally offer training programs for fertility specialists and embryologists. Under the Triesta emblem, it provides medical reference laboratory services with specialization in oncology.

HealthcareGlobal Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

HealthcareGlobal Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	352	358	365	408	420	425	442	461	487	470
Other Income	3	3	3	3	2	4	5	2	3	6
Total Income	355	361	368	411	422	428	446	463	490	476
Total Expenditure	290	296	301	336	345	349	365	386	402	391
Operating Profit	65	65	66	75	77	79	81	77	88	85
Interest	23	24	24	25	26	27	26	26	27	29
Depreciation	38	41	41	40	41	41	42	41	43	44
Exceptional Income / Expenses	140	-46	0	0	0	0	0	0	0	0
Profit Before Tax	144	-46	1	10	10	11	13	10	18	11
Provision for Tax	43	4	-1	8	5	7	7	7	7	8
Profit After Tax	101	-50	2	2	5	4	6	3	11	3
Adjustments	2	4	4	4	2	3	3	4	3	2
Profit After Adjustments	103	-46	6	6	7	8	8	8	14	6
Adjusted Earnings Per Share	8.2	-3.3	0.4	0.4	0.5	0.5	0.6	0.5	1	0.4

HealthcareGlobal Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	345	450	519	584	700	829	976	1092	1009	1395	1691	1860
Other Income	3	5	5	4	10	19	10	10	21	16	32	16
Total Income	348	455	524	588	710	848	986	1103	1030	1410	1723	1875
Total Expenditure	293	413	443	499	595	716	853	923	887	1160	1411	1544
Operating Profit	54	42	81	89	115	132	133	179	144	251	312	331
Interest	29	32	34	38	23	42	70	138	119	98	104	108
Depreciation	30	36	39	44	57	71	85	148	159	158	163	170
Exceptional Income / Expenses	0	-10	-5	-6	0	11	0	0	-93	95	0	0
Profit Before Tax	-5	-36	3	0	35	27	-33	-119	-229	88	45	52
Provision for Tax	1	5	-2	-2	12	10	-3	6	-8	49	27	29
Profit After Tax	-5	-42	5	2	23	17	-31	-125	-221	39	18	23
Adjustments	-1	-2	-4	-4	-1	4	6	19	28	15	12	12
Profit After Adjustments	-6	-44	1	-1	22	21	-25	-107	-193	54	29	36
Adjusted Earnings Per Share	-0.9	-6.4	0.1	-0.2	2.6	2.4	-2.8	-12	-15.4	3.9	2.1	2.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	21%	16%	15%	17%
Operating Profit CAGR	24%	20%	19%	19%
PAT CAGR	-54%	0%	1%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	29%	23%	13%	NA%
ROE Average	2%	-12%	-14%	-7%
ROCE Average	12%	6%	4%	5%

HealthcareGlobal Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	292	263	279	426	433	515	477	381	697	870	861
Minority's Interest	17	18	25	33	57	64	46	39	17	13	9
Borrowings	239	252	280	246	283	372	517	530	346	363	362
Other Non-Current Liabilities	17	5	-2	60	71	110	40	702	476	497	509
Total Current Liabilities	156	149	187	263	366	359	547	576	465	470	570
Total Liabilities	721	688	770	1027	1210	1421	1627	2227	2001	2214	2311
Fixed Assets	506	511	528	583	685	828	970	1646	1382	1547	1553
Other Non-Current Assets	51	68	120	217	281	373	384	277	184	164	177
Total Current Assets	164	109	122	227	244	220	273	304	435	502	580
Total Assets	721	688	770	1027	1210	1421	1627	2227	2001	2214	2311

HealthcareGlobal Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	16	11	22	-5	80	51	27	-29	-59	3	193
Cash Flow from Operating Activities	29	50	60	73	91	98	99	130	121	220	252
Cash Flow from Investing Activities	-100	-58	-80	-204	-210	-282	-238	-101	-171	125	-133
Cash Flow from Financing Activities	66	23	22	216	89	161	84	-58	112	-155	-140
Net Cash Inflow / Outflow	-6	15	2	85	-29	-23	-56	-30	62	190	-22
Closing Cash & Cash Equivalent	11	25	25	80	51	27	-29	-59	3	193	171

HealthcareGlobal Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0.91	-6.4	0.12	-0.17	2.59	2.36	-2.82	-12.03	-15.43	3.87	2.11
CEPS(Rs)	3.68	-0.78	6.28	5.44	9.32	10.17	6.17	2.59	-4.94	14.19	13.02
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	43.46	38.2	39.32	49.95	50.34	55.4	53.58	42.19	51.57	62.12	60.99
Core EBITDA Margin(%)	15.03	8.22	14.68	14.51	15	13.56	12.56	15.46	12.12	16.85	16.57
EBIT Margin(%)	7.08	-0.9	7.17	6.61	8.26	8.39	3.74	1.68	-10.85	13.3	8.77
Pre Tax Margin(%)	-1.37	-8.06	0.58	0.05	4.98	3.28	-3.42	-10.92	-22.66	6.29	2.65
PAT Margin (%)	-1.58	-9.25	0.9	0.38	3.29	2.04	-3.16	-11.48	-21.91	2.79	1.04
Cash Profit Margin (%)	7.12	-1.19	8.46	7.93	11.41	10.67	5.55	2.1	-6.13	14.14	10.71
ROA(%)	-0.89	-5.91	0.64	0.25	2.06	1.29	-2.03	-6.51	-10.46	1.85	0.78
ROE(%)	-2.16	-15.1	1.75	0.64	5.38	3.71	-6.48	-29.68	-43.32	5.16	2.06
ROCE(%)	4.74	-0.71	6.41	5.6	7.22	7.59	3.46	1.65	-9.66	15.17	11.69
Receivable days	56.23	46.58	40.71	41.66	45.03	51.01	53.35	57.23	67.32	52.87	56.1
Inventory Days	9.01	8.9	9.32	8.72	8.37	9.42	9.5	8.36	8.02	6.68	7.36
Payable days	156.93	168.6	192.21	233.18	251.77	259.58	246.42	233.06	227.13	174.56	190.39
PER(x)	0	0	0	0	89.12	124.03	0	0	0	69.83	124.52
Price/Book(x)	0	0	0	3.58	4.58	5.29	4.02	1.78	3.7	4.34	4.31
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	1.05	0.69	0.75	3.06	3.3	3.6	2.59	1.24	2.8	2.84	2.28
EV/Core EBITDA(x)	6.68	7.4	4.83	20.16	20.16	22.64	19.09	7.53	19.69	15.81	12.37
Net Sales Growth(%)	27.98	30.33	15.4	12.48	19.85	18.38	17.77	11.92	-7.61	38.21	21.27
EBIT Growth(%)	4.7	-116.5	1023.13	3.66	49.82	20.2	-47.45	-49.69	-695.69	269.45	-20.03
PAT Growth(%)	-539.19	-664.27	111.29	-52.33	929.16	-26.49	-282.28	-306.33	-76.24	117.6	-54.71
EPS Growth(%)	-228.98	-602.63	101.86	-244.04	1606.64	-8.71	-219.43	-326.54	-28.28	125.05	-45.42
Debt/Equity(x)	1.06	1.04	1.27	0.76	0.97	0.96	1.4	1.91	0.73	0.47	0.47
Current Ratio(x)	1.05	0.73	0.65	0.87	0.67	0.61	0.5	0.53	0.93	1.07	1.02
Quick Ratio(x)	0.99	0.65	0.57	0.81	0.62	0.55	0.45	0.49	0.89	1.01	0.95
Interest Cover(x)	0.84	-0.13	1.09	1.01	2.52	1.64	0.52	0.13	-0.92	1.9	1.43
Total Debt/Mcap(x)	0	0	0	0.21	0.21	0.18	0.35	1.08	0.2	0.11	0.11

HealthcareGlobal Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	71.44	71.43	71.42	71.39	71.38	71.37	71.35	71.3	71.29	71.28
FII	7.03	6.99	7.22	7.27	7.17	6.37	6.47	6.28	6.36	6.74
DII	6.59	5.85	4.55	4.03	4.4	5.54	6.58	7.94	8.46	8.52
Public	14.94	15.73	16.81	17.31	17.04	16.72	15.59	14.48	13.89	13.46
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93
FII	0.98	0.97	1	1.01	1	0.89	0.9	0.88	0.89	0.94
DII	0.92	0.81	0.63	0.56	0.61	0.77	0.92	1.11	1.18	1.19
Public	2.08	2.19	2.34	2.41	2.37	2.33	2.17	2.02	1.93	1.87
Others	0	0	0	0	0	0	0	0	0	0
Total	13.9	13.9	13.9	13.91	13.91	13.91	13.92	13.93	13.93	13.93

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Company has a low return on equity of -12% over the last 3 years.
Debtor days have increased from 174.56 to 190.39days.
Stock is trading at 5.7 times its book value.
The company has delivered a poor profit growth of 1% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

HealthcareGlobal News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

HealthcareGlobal

Add Watchlist

HealthcareGlobal Research see more...

Overview Inc. Year: 1998Industry: Hospital & Healthcare Services

HealthcareGlobal Share Price

Alert Data

Quarterly Price

Peer Comparison

HealthcareGlobal Quarterly Results

HealthcareGlobal Profit & Loss

Growth Rates

HealthcareGlobal Balance Sheet

HealthcareGlobal Cash Flow

HealthcareGlobal Ratios

HealthcareGlobal Shareholding Pattern

HealthcareGlobal News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!